(RTTNews) - Insulet (PODD) reported third quarter net income of $141.1 million, or $2.03 per diluted share, compared to $87.6 million, or $1.24 per diluted share, prior year. Adjusted net income was $138.0 million, increased 57.2% compared to $87.8 million in the prior year. Adju

Insulet Q3 Net Income Rises; Issues FY26 Outlook 

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Align Technology Inc (Symbol: ALGN) has taken over the #479 spot from Insulet Corp (Symbol: PODD), according to The Online Investor.  

	Market capitalization is an impor

Align Technology Takes Over #479 Spot From Insulet 

Fintel reports that on October 7, 2026, Barclays initiated coverage of Insulet (NASDAQGS:PODD) (LSE:0ADR) with a Equal-Weight recommendation. This initiation follows a prior action on May 8, 2026, when the firm maintained its Underweight rating on the stock.Prior to this initiati

Barclays Initiates Coverage of Insulet with Equal-Weight Rating

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Insulet Corporation News